NCT01734707View on ClinicalTrials.gov

Atherosclerosis Monitoring and Atherogenicity Reduction Study

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

October 31, 2005

Conditions
Carotid Atherosclerosis
Interventions
DIETARY_SUPPLEMENT

Allicor

DRUG

Placebo

Sugar pill manufactured to mimic Allicor 150 mg tablet

Trial Locations (1)

Unknown

Institute for Atherosclerosis Research, Moscow

All Listed Sponsors
lead

Institute for Atherosclerosis Research, Russia

OTHER

NCT01734707 - Atherosclerosis Monitoring and Atherogenicity Reduction Study | Biotech Hunter | Biotech Hunter